Home > News > Headline News > Archive

Click on title to read the full article.

Exciting New Breast Cancer Drug Poised to Break the Bank?

October 30, 2012

By Peter Ubel, Contributor - Forbes

In exciting news for breast cancer patients, the FDA recently approved Perjeta, a new treatment for metastatic breast cancer that delays progression of the disease by six months. But can we afford to offer this drug to every woman who could potentially benefit?


Genetic testing changes breast cancer focus

October 28, 2012

By Tom Corwin, The Augusta Chronicle

In the near future, Dr. Olivier Rixe said, we might stop talking about breast cancer altogether.

As genetic sequencing of tumors becomes more routine and therapies are targeted at specific molecular traits in the tumor, the location of the primary tumor becomes less important, said Rixe, the director of the experimental therapeutics program at Georgia Health Scien­ces University's Cancer Center.


Metastatic Breast Cancer Network Presents Dr. Patricia Steeg with the Ellen Moskowitz &Suzanne Hebert Leadership Grant

October 22, 2012


Contact: Metastatic Breast Cancer Network (MBCN)
Contact Person: Katherine O’Brien
Telephone Number: 888-500-0370 (voice mail)
Email Address: mbcn@mbcn.org

Web site: www.mbcn.org



October With Metastatic Breast Cancer

October 18, 2012

By Elaine Schattner, The Atlantic

"Are you here for the breast cancer party?" asked the waitress. She wore a black tee shirt and carried a round tray with drinks. She stood by the entry while other women filed into Gino's East pizzeria on Superior Street in Chicago. The elevator was packed.

"That'd be on three," the server said. She hit the button and exited.

On that recent October evening, some 150 people gathered for a welcome reception and dinner of the Metastatic Breast Cancer Network (MBCN). The bulk of the group -- mainly women living with Stage IV disease, along with a few husbands, moms, and other caregivers -- were in town for the organization's sixth annual conference.


Noncancerous cells carry weight

October 16, 2012

By Bonnie Prescott

In recent years investigators have discovered that breast tumors are influenced by more than just the cancer cells within them. A variety of noncancerous cells, which in many cases constitute the majority of the tumor mass, form what is known as the "tumor microenvironment." This sea of noncancerous cells and the products they deposit appear to play key roles in tumor pathogenesis.


NCI Cancer Bulletin - Vol. 9; No. 20

October 14, 2012

By National Cancer Institute

Articles Include: Treatment Options for HER2-Positive Breast Cancer Expand and Evolve

HIV Drug Blocks Growth of HER2-Positive Breast Cancer Cells

Basser Research Center: Focusing on BRCA-Related Cancers


One Pink Ribbon Message That Needs More Attention

October 12, 2012

By Heidi Pashman, Shape

October is the month we have visions of pink ribbons dancing in our heads. Organizations, patients, family members, and friends collaborate to "hear it for the girls," think pink, and celebrate breast cancer survivors to encourage females everywhere to get a mammogram or a do a simple self breast exam, hoping to save another life.


'Pinktober' ignores breast cancer patients who can't be cured, some say

October 12, 2012

By JoNel Aleccia, NBC News

Here we are, nearly halfway through October, and Laura Wells can't wait for Breast Cancer Awareness month to end.

Not that she has any time to spare for walks and such: Wells is among some 155,000 women in the United States living with Stage IV breast cancer, the worst kind, the type that can't be cured.

AstraZeneca Recognizes Metastatic Breast Cancer Awareness Day on October 13

October 10, 2012

WILMINGTON, Del., October 09, 2012 /PRNewswire/ - In recognition of Metastatic Breast Cancer Awareness Day on October 13, AstraZeneca (NYSE: AZN) is raising awareness about the thousands of U.S. women living with metastatic breast cancer. Metastatic Breast Cancer Awareness Day seeks to generate attention and greater support for women living with metastatic breast cancer among the public and stakeholders within the breast cancer community and more research to extend lives.


Are You Aware How LITTLE Has Changed in Breast Cancer in 25 Years?

October 9, 2012

By Fran Visco, National Breast Cancer Coalition President

Twenty-five years ago, I sat in my doctor's office and heard these words: You have breast cancer. That was in 1987, when the world's population reached five billion, a gallon of gas was 89 cents, Ronald Reagan was president and the FDA approved AZT for AIDS.

I was 39 years old and a litigator at a Philadelphia law firm. My husband and I were enjoying being parents to our 14-month-old son. I paid attention to politics and to women's issues and served as a community volunteer.


 1 2 >